View in EDS

Temporal distribution and clinical characteristics of the Alpha, Delta and Omicron SARS-CoV-2 variants of concern in Laikipia, Kenya: institutional and community-based genomic surveillance.

Saved in:
Bibliographic Details
Title: Temporal distribution and clinical characteristics of the Alpha, Delta and Omicron SARS-CoV-2 variants of concern in Laikipia, Kenya: institutional and community-based genomic surveillance.
Authors: Lambisia, Arnold W.1 alambisia@kemri-wellcome.org, Mudhune, Godfrey H.2 mudhuneg@gmail.com, Morobe, John M.1, Mohammed, Khadija Said1, Makori, Timothy O.1, Ndwiga, Leonard1, Mburu, Maureen W.1, Moraa, Edidah O.1, Musyoki, Jeniffer1, Murunga, Nickson1, Waliaula, Isaac N.2, Mumelo, Arthur K.2, Bejon, Philip1,3, Ochola-Oyier, Lynette Isabella1, Githinji, George1,4, Nokes, James1,5, Agoti, Charles1,4
Source: Wellcome Open Research. 2023, p1-17. 17p.
Subject Terms: Molecular epidemiology, COVID-19 pandemic, Phylogenetic models, Clinical trials, Clinical medicine research
Abstract: Background: Understanding the molecular epidemiology and clinical presentation of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) in rural-urban populations in Kenya is important for informing future public health responses and clinical care. Methods: We undertook a retrospective analysis of the clinical presentation and phylogenetic relatedness of specimens from 97 SARS-CoV-2 cases collected between 24th April and 31st December 2021 in Laikipia county, Kenya. VOC were related to observed symptoms. Phylogenetic analyses included contemporaneous sequences from across Kenya and the globe, to contextualise local transmission dynamics. Results: These sequences fell into three VOC; Alpha (n=8), Delta (n=52) and Omicron (n=37). We estimated 75 independent SARS-CoV-2 introductions into the county. The Alpha and Delta VOC were commonly detected in persons aged 31 to 45 years, 50.0% and 30.8%, respectively. The Omicron VOC was mostly detected in 16 to 30-yearolds (51.4%). Whereas relative to the other VOCs, Omicron was associated with mild upper-respiratory tract symptoms (cough, OR 3.78; 95% CI 1.1 – 16.74, p= 0.026) and sore throat, OR 22.42; 95% CI 7.11 – 81.40, p<0.001), Delta was associated with moderate to severe lower-respiratory tract symptoms (shortness of breath, OR 26.8; 95% CI 3.89 – 1158.14, p<0.001) and fever (OR 6.11; 95% CI 1.57 – 35.35, p= 0.004). Post-acute phase neurological complications were suspected in four Delta infected cases (neuralgia, neuritis, peripheral neuropathy, numbness of hand and tinnitus). Conclusion: We highlight the distinctive clinical characteristics of SARS-CoV-2 VOCs, as observed in Laikipia, Kenya, to support evidence-based clinical decisions. Multiple introductions of the VOCs were recorded despite the public health measures that were in place questioning their effectiveness during the study period. [ABSTRACT FROM AUTHOR]
Copyright of Wellcome Open Research is the property of Wellcome Trust and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: GreenFILE
FullText Text:
  Availability: 0
Header DbId: 8gh
DbLabel: GreenFILE
An: 189198151
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Temporal distribution and clinical characteristics of the Alpha, Delta and Omicron SARS-CoV-2 variants of concern in Laikipia, Kenya: institutional and community-based genomic surveillance.
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Lambisia%2C+Arnold+W%2E%22&quot;&gt;Lambisia, Arnold W.&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;i&gt; alambisia@kemri-wellcome.org&lt;/i&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Mudhune%2C+Godfrey+H%2E%22&quot;&gt;Mudhune, Godfrey H.&lt;/searchLink&gt;&lt;relatesTo&gt;2&lt;/relatesTo&gt;&lt;i&gt; mudhuneg@gmail.com&lt;/i&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Morobe%2C+John+M%2E%22&quot;&gt;Morobe, John M.&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Mohammed%2C+Khadija+Said%22&quot;&gt;Mohammed, Khadija Said&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Makori%2C+Timothy+O%2E%22&quot;&gt;Makori, Timothy O.&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Ndwiga%2C+Leonard%22&quot;&gt;Ndwiga, Leonard&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Mburu%2C+Maureen+W%2E%22&quot;&gt;Mburu, Maureen W.&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Moraa%2C+Edidah+O%2E%22&quot;&gt;Moraa, Edidah O.&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Musyoki%2C+Jeniffer%22&quot;&gt;Musyoki, Jeniffer&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Murunga%2C+Nickson%22&quot;&gt;Murunga, Nickson&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Waliaula%2C+Isaac+N%2E%22&quot;&gt;Waliaula, Isaac N.&lt;/searchLink&gt;&lt;relatesTo&gt;2&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Mumelo%2C+Arthur+K%2E%22&quot;&gt;Mumelo, Arthur K.&lt;/searchLink&gt;&lt;relatesTo&gt;2&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Bejon%2C+Philip%22&quot;&gt;Bejon, Philip&lt;/searchLink&gt;&lt;relatesTo&gt;1,3&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Ochola-Oyier%2C+Lynette+Isabella%22&quot;&gt;Ochola-Oyier, Lynette Isabella&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Githinji%2C+George%22&quot;&gt;Githinji, George&lt;/searchLink&gt;&lt;relatesTo&gt;1,4&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Nokes%2C+James%22&quot;&gt;Nokes, James&lt;/searchLink&gt;&lt;relatesTo&gt;1,5&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Agoti%2C+Charles%22&quot;&gt;Agoti, Charles&lt;/searchLink&gt;&lt;relatesTo&gt;1,4&lt;/relatesTo&gt;
– Name: TitleSource
  Label: Source
  Group: Src
  Data: &lt;searchLink fieldCode=&quot;JN&quot; term=&quot;%22Wellcome+Open+Research%22&quot;&gt;Wellcome Open Research&lt;/searchLink&gt;. 2023, p1-17. 17p.
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Molecular+epidemiology%22&quot;&gt;Molecular epidemiology&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22COVID-19+pandemic%22&quot;&gt;COVID-19 pandemic&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Phylogenetic+models%22&quot;&gt;Phylogenetic models&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Clinical+trials%22&quot;&gt;Clinical trials&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Clinical+medicine+research%22&quot;&gt;Clinical medicine research&lt;/searchLink&gt;
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background: Understanding the molecular epidemiology and clinical presentation of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) in rural-urban populations in Kenya is important for informing future public health responses and clinical care. Methods: We undertook a retrospective analysis of the clinical presentation and phylogenetic relatedness of specimens from 97 SARS-CoV-2 cases collected between 24th April and 31st December 2021 in Laikipia county, Kenya. VOC were related to observed symptoms. Phylogenetic analyses included contemporaneous sequences from across Kenya and the globe, to contextualise local transmission dynamics. Results: These sequences fell into three VOC; Alpha (n=8), Delta (n=52) and Omicron (n=37). We estimated 75 independent SARS-CoV-2 introductions into the county. The Alpha and Delta VOC were commonly detected in persons aged 31 to 45 years, 50.0% and 30.8%, respectively. The Omicron VOC was mostly detected in 16 to 30-yearolds (51.4%). Whereas relative to the other VOCs, Omicron was associated with mild upper-respiratory tract symptoms (cough, OR 3.78; 95% CI 1.1 – 16.74, p= 0.026) and sore throat, OR 22.42; 95% CI 7.11 – 81.40, p&lt;0.001), Delta was associated with moderate to severe lower-respiratory tract symptoms (shortness of breath, OR 26.8; 95% CI 3.89 – 1158.14, p&lt;0.001) and fever (OR 6.11; 95% CI 1.57 – 35.35, p= 0.004). Post-acute phase neurological complications were suspected in four Delta infected cases (neuralgia, neuritis, peripheral neuropathy, numbness of hand and tinnitus). Conclusion: We highlight the distinctive clinical characteristics of SARS-CoV-2 VOCs, as observed in Laikipia, Kenya, to support evidence-based clinical decisions. Multiple introductions of the VOCs were recorded despite the public health measures that were in place questioning their effectiveness during the study period. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: &lt;i&gt;Copyright of Wellcome Open Research is the property of Wellcome Trust and its content may not be copied or emailed to multiple sites without the copyright holder&#39;s express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=8gh&AN=189198151
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.12688/wellcomeopenres.18306.2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 17
        StartPage: 1
    Subjects:
      – SubjectFull: Molecular epidemiology
        Type: general
      – SubjectFull: COVID-19 pandemic
        Type: general
      – SubjectFull: Phylogenetic models
        Type: general
      – SubjectFull: Clinical trials
        Type: general
      – SubjectFull: Clinical medicine research
        Type: general
    Titles:
      – TitleFull: Temporal distribution and clinical characteristics of the Alpha, Delta and Omicron SARS-CoV-2 variants of concern in Laikipia, Kenya: institutional and community-based genomic surveillance.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lambisia, Arnold W.
      – PersonEntity:
          Name:
            NameFull: Mudhune, Godfrey H.
      – PersonEntity:
          Name:
            NameFull: Morobe, John M.
      – PersonEntity:
          Name:
            NameFull: Mohammed, Khadija Said
      – PersonEntity:
          Name:
            NameFull: Makori, Timothy O.
      – PersonEntity:
          Name:
            NameFull: Ndwiga, Leonard
      – PersonEntity:
          Name:
            NameFull: Mburu, Maureen W.
      – PersonEntity:
          Name:
            NameFull: Moraa, Edidah O.
      – PersonEntity:
          Name:
            NameFull: Musyoki, Jeniffer
      – PersonEntity:
          Name:
            NameFull: Murunga, Nickson
      – PersonEntity:
          Name:
            NameFull: Waliaula, Isaac N.
      – PersonEntity:
          Name:
            NameFull: Mumelo, Arthur K.
      – PersonEntity:
          Name:
            NameFull: Bejon, Philip
      – PersonEntity:
          Name:
            NameFull: Ochola-Oyier, Lynette Isabella
      – PersonEntity:
          Name:
            NameFull: Githinji, George
      – PersonEntity:
          Name:
            NameFull: Nokes, James
      – PersonEntity:
          Name:
            NameFull: Agoti, Charles
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 2398502X
          Titles:
            – TitleFull: Wellcome Open Research
              Type: main
ResultId 1